These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32591618)

  • 1. RIPK3 blockade attenuates tubulointerstitial fibrosis in a mouse model of diabetic nephropathy.
    Shi Y; Huang C; Zhao Y; Cao Q; Yi H; Chen X; Pollock C
    Sci Rep; 2020 Jun; 10(1):10458. PubMed ID: 32591618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RIPK3 blockade attenuates kidney fibrosis in a folic acid model of renal injury.
    Shi Y; Huang C; Yi H; Cao Q; Zhao Y; Chen J; Chen X; Pollock C
    FASEB J; 2020 Aug; 34(8):10286-10298. PubMed ID: 32542792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.
    Birnbaum Y; Bajaj M; Yang HC; Ye Y
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):135-145. PubMed ID: 29508169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome.
    Seo JB; Choi YK; Woo HI; Jung YA; Lee S; Lee S; Park M; Lee IK; Jung GS; Park KG
    Diabetes Metab J; 2019 Dec; 43(6):830-839. PubMed ID: 30877711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects and mechanisms of total flavones of Abelmoschus manihot in inhibiting podocyte necroptosis and renal fibrosis in diabetic kidney disease].
    Chen JX; Fang QJ; Wan YG; Liu YL; Wang Y; Wu W; Tu Y; Wang MZ; Wang DG; Ge HT
    Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(15):4137-4146. PubMed ID: 37802782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease.
    Østergaard JA; Jha JC; Sharma A; Dai A; Choi JSY; de Haan JB; Cooper ME; Jandeleit-Dahm K
    Clin Sci (Lond); 2022 Jan; 136(2):167-180. PubMed ID: 35048962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice.
    Wu M; Han W; Song S; Du Y; Liu C; Chen N; Wu H; Shi Y; Duan H
    Mol Cell Endocrinol; 2018 Dec; 478():115-125. PubMed ID: 30098377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
    Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
    J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of RIPK1/RIPK3 ameliorates osteoclastogenesis through regulating NLRP3-dependent NF-κB and MAPKs signaling pathways.
    Liang S; Nian Z; Shi K
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1028-1035. PubMed ID: 32321638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation.
    Wang S; Li Y; Fan J; Zhang X; Luan J; Bian Q; Ding T; Wang Y; Wang Z; Song P; Cui D; Mei X; Ju D
    Cell Death Dis; 2017 Jul; 8(7):e2937. PubMed ID: 28726774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of the NLRP3 inflammasome.
    Ding H; Li J; Li Y; Yang M; Nie S; Zhou M; Zhou Z; Yang X; Liu Y; Hou FF
    Mol Ther; 2021 Jul; 29(7):2308-2320. PubMed ID: 33744467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ChREBP Deficiency Suppresses Renal Inflammation and Fibrosis Via Inhibiting NLRP3 Inflammasome Activation in Diabetic Kidney Disease.
    Chen N; Yang Z; Mu L; Wu M; Song J; Zhou T; Shi Y
    Discov Med; 2022; 33(169):69-83. PubMed ID: 36274225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Selective NLRP3-Inflammasome Inhibitor CY-09 Ameliorates Kidney Injury in Diabetic Nephropathy by Inhibiting NLRP3- inflammasome Activation.
    Yang M; Zhao L
    Curr Med Chem; 2023; 30(28):3261-3270. PubMed ID: 36154582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The eNOS-NO pathway attenuates kidney dysfunction via suppression of inflammasome activation in aldosterone-induced renal injury model mice.
    Sogawa Y; Nagasu H; Itano S; Kidokoro K; Taniguchi S; Takahashi M; Kadoya H; Satoh M; Sasaki T; Kashihara N
    PLoS One; 2018; 13(10):e0203823. PubMed ID: 30281670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Marrow-Derived RIPK3 Mediates Kidney Inflammation in Acute Kidney Injury.
    Martin-Sanchez D; Guerrero-Mauvecin J; Fontecha-Barriuso M; Mendez-Barbero N; Saiz ML; Lopez-Diaz AM; Sanchez-Niño MD; Carrasco S; Cannata-Ortiz P; Ruiz-Ortega M; Ortiz A; Sanz AB
    J Am Soc Nephrol; 2022 Feb; 33(2):357-373. PubMed ID: 35046131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor.
    Ye Y; Bajaj M; Yang HC; Perez-Polo JR; Birnbaum Y
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):119-132. PubMed ID: 28447181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
    Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
    Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL.
    Lawlor KE; Khan N; Mildenhall A; Gerlic M; Croker BA; D'Cruz AA; Hall C; Kaur Spall S; Anderton H; Masters SL; Rashidi M; Wicks IP; Alexander WS; Mitsuuchi Y; Benetatos CA; Condon SM; Wong WW; Silke J; Vaux DL; Vince JE
    Nat Commun; 2015 Feb; 6():6282. PubMed ID: 25693118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome.
    Ma Z; Zhu L; Wang S; Guo X; Sun B; Wang Q; Chen L
    Ren Fail; 2022 Dec; 44(1):923-932. PubMed ID: 35618411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of Histone Deacetylase 6 Ameliorates Podocyte Injury in Diabetic Kidney Disease in Mice].
    Hou Q; Kan S; Zhang M; Xu F; Liu Z; Jiang S
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1097-1104. PubMed ID: 38162083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.